Headache FSN2026 | 2026 Annual Meeting of the Florida Society of Neurology

EVALUATION

2026 Annual Meeting of the Florida Society of Neurology
Headache, Epilepsy, MS, Neuromuscular

Saturday, January 17, 2025 – Sunday, January 18, 2025
Name*

First NameLast Name
Degree
Email*
example@example.com
MDNPRNPAPharmDPsychologistProfessorIndustryOther
NeurologistFamily/GeneralInternistPrimary CareOther
How many years have you been in practice?
How many patients do you typically see each month?
a. small fiber neuropathy.b. vasculitis.c. hereditary neuropathy.d. inflammatory polyradiculoneuropathy.e. chemotherapy induced neuropathy.
a. history of chemptherapy.b. history of poorly controlled diabetes mellitus.c. presence of conduction block on electrodiagnostic studies.d. anti-MAG antobodies.e. IgM monoclonal protein.
a. efgartigimod.b. IVIg.c. methotrexate.d. corticosteroids.e. plasma exchange.
a. Reducing hepatic production of mutant and wild type TTR through RNA interference or antisense mechanismsb. Stabilizing the TTR tetramer to prevent dissociationc. Enhancing amyloid fibril clearance by macrophagesd. Blocking amyloid fibril binding to peripheral nervese. Inhibiting the complement pathway to prevent amyloid formation
a. Isolated progressive motor weaknessb. Slowly progressive distal sensory polyneuropathyc. Rapidly progressive axonal sensorimotor polyneuropathy with autonomic featuresd. Pure small fiber neuropathy without systemic involvemente. Progressive length dependent demyelinating polyneuropathy
a. Secretory diarrheab. Renal failure with proteinuriac. Macroglossiad. Bilateral carpal tunnel syndrome and lumbar spinal stenosise. Weight loss
a. Rozanolixizumabb. Efgartigimodc. Nipocalimabd. Zilucoplane. Azathioprine
a. Decrease T cell function after binding to the FcRn receptor in the lymph nodesb. Decrease antibody production after reducing immunoglobulin synthesis by plasma cellsc. Decreased lymphocyte production after binding to the FcRn receptor in the bone marrowd. Decrease IgG immunoglobulin levels after reducing the recycling of immunoglobulin IgGe. Decrease complement levels after binding the FcRn complement receptor

Please rate your experience at the activity:

Rows	Poor	Fair	Good	Very Good	Excellent
Overall, this activity met my learning needs.
The information presented was without promotional or commercial bias.
The content was scientifically rigorous and evidence based.
The educational format provided appropriate and effective opportunities for active learning (e.g., discussion, Q&A).
The quality of the educational process was satisfactory and appropriate.
The education promoted improvements for quality in health care

Please rate the extent to which this activity met the following objectives:

Rows	Poor	Fair	Good	Very Good	Excellent
The Florida Neurologist will be updated in contemporary management strategies and will have gained information to avoid burnout and maintain humanism in practice.
The Florida General Practitioner will know how to recognize, localize, and treat common neurological disorders.
The Florida Neurologist-In-Training will have further developed the skills of analytical thinking and appreciate the value of life-long learning, our yearly goal.

a. Update treatment plan(s)b. Office staff educationc. Healthcare referral team educationd. Patient educatione. Implement a new procedure/protocolf. Discuss new information with colleaguesg. Modification of current practiceh. All of the abovei. None of the above
a. Treatment availabilityb. Financial/Insurance restrictionsc. Patient complianced. Patient educatione. Healthcare team support/resourcesf. Time to assess or counsel patientsg. Profession guidelinesh. All of the abovei. No perceived barriers
YesNo
If yes, please explain:
Please provide any additional comments related to the activity:
Attestation: This activity is certified for a maximum of 18.0 AMA PRA Category 1 Credits™. I participated in this activity and claim __________ credits.*
Course Title
Date
Should be Empty: